News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Proceeds from the financing will be used to advance Capstan's lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, CPTX2309, to early clinical proof-of-concept in autoimmune disorders.
Utilizing ARCUS, a gene editing tool developed by Precision BioSciences, the therapy aims to provide a lifelong fix for this disease, potentially benefiting thousands of individuals in the US alone.
The Senate Republican Policy Committee convened a public hearing exploring Pennsylvania’s role as an innovation hub and the importance of startups and established companies.
Researchers at Penn led by Ben Black, PhD, the Eldridge Reeves Johnson Foundation Professor of Biochemistry and Biophysics, have found a new way to create synthetic chromosomes.
Through our training in customer discovery, participants learn how to identify a niche market for their innovations, guiding them from idea to impact.
Penn Engineering has introduced its Bachelor of Science in Engineering in Artificial Intelligence (AI) degree, which is the first undergraduate major of its kind among Ivy League universities.
Amplify Philly, along with PCI and other partners, hosted the first ever Innovation Press Preview Event & Gathering on February 16, 2024 at the Philadelphia Science Center.
According to the report, the Philadelphia area had a stronger performance than many other, larger venture funding hot spots, particularly at the pre-seed and seed stages.
Baleena is focused on developing a consumer product that attaches to the inside of a washing machine drum to filter out microfibers.
This year, Penn spinouts BlueWhale Bio and Baleena, ranked number one and two on the RealLIST respectively.